KR20230086836A - A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same - Google Patents
A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same Download PDFInfo
- Publication number
- KR20230086836A KR20230086836A KR1020210174435A KR20210174435A KR20230086836A KR 20230086836 A KR20230086836 A KR 20230086836A KR 1020210174435 A KR1020210174435 A KR 1020210174435A KR 20210174435 A KR20210174435 A KR 20210174435A KR 20230086836 A KR20230086836 A KR 20230086836A
- Authority
- KR
- South Korea
- Prior art keywords
- rice
- powder
- porridge
- pea
- premix
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 123
- 235000009566 rice Nutrition 0.000 title claims abstract description 123
- 235000021395 porridge Nutrition 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 40
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 40
- 241000209094 Oryza Species 0.000 title claims abstract 33
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 111
- 240000004713 Pisum sativum Species 0.000 claims abstract description 92
- 239000000843 powder Substances 0.000 claims abstract description 71
- 150000001413 amino acids Chemical class 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 27
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 27
- 239000011707 mineral Substances 0.000 claims abstract description 27
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 229960002477 riboflavin Drugs 0.000 claims abstract description 12
- 108091005804 Peptidases Proteins 0.000 claims abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004365 Protease Substances 0.000 claims abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011575 calcium Substances 0.000 claims abstract description 8
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 8
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 239000011777 magnesium Substances 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 239000011701 zinc Substances 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 6
- 239000002151 riboflavin Substances 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 6
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 6
- 229940045997 vitamin a Drugs 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 241000219843 Pisum Species 0.000 claims abstract 19
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract 2
- 235000018102 proteins Nutrition 0.000 claims description 36
- 229940024606 amino acid Drugs 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 244000068988 Glycine max Species 0.000 claims description 13
- 235000010469 Glycine max Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- 229960000310 isoleucine Drugs 0.000 claims description 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- 102000035195 Peptidases Human genes 0.000 claims description 5
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims description 4
- 244000043158 Lens esculenta Species 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- 240000006677 Vicia faba Species 0.000 claims description 3
- 235000010749 Vicia faba Nutrition 0.000 claims description 3
- 235000002098 Vicia faba var. major Nutrition 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 abstract 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 230000018984 mastication Effects 0.000 abstract 1
- 238000010077 mastication Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 description 90
- 235000010755 mineral Nutrition 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 17
- 230000036039 immunity Effects 0.000 description 17
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 15
- 235000016709 nutrition Nutrition 0.000 description 15
- 230000008859 change Effects 0.000 description 12
- 235000013305 food Nutrition 0.000 description 10
- 108010084695 Pea Proteins Proteins 0.000 description 9
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 9
- 235000019702 pea protein Nutrition 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 230000015788 innate immune response Effects 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 6
- 108010074328 Interferon-gamma Proteins 0.000 description 6
- 102000013462 Interleukin-12 Human genes 0.000 description 6
- 108010065805 Interleukin-12 Proteins 0.000 description 6
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- 102000004889 Interleukin-6 Human genes 0.000 description 6
- 108090001005 Interleukin-6 Proteins 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 230000001055 chewing effect Effects 0.000 description 6
- 239000012228 culture supernatant Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000005778 DNA damage Effects 0.000 description 5
- 231100000277 DNA damage Toxicity 0.000 description 5
- 238000008157 ELISA kit Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229940117681 interleukin-12 Drugs 0.000 description 5
- 229940100601 interleukin-6 Drugs 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 235000019750 Crude protein Nutrition 0.000 description 4
- 102100037850 Interferon gamma Human genes 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000004820 blood count Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 102000006395 Globulins Human genes 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000003927 comet assay Methods 0.000 description 2
- 231100000170 comet assay Toxicity 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 108060006613 prolamin Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 101100508420 Mus musculus Ifng gene Proteins 0.000 description 1
- 101001076414 Mus musculus Interleukin-6 Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N Nitrogen oxide(NO) Natural products O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- -1 Protamex Proteins 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003840 blood vessel health Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 108010007119 flavourzyme Proteins 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000019734 interleukin-12 production Effects 0.000 description 1
- 230000004073 interleukin-2 production Effects 0.000 description 1
- 230000017306 interleukin-6 production Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- ACCDBHBOYZJSDT-UHFFFAOYSA-N n-(4-bromophenyl)-2-fluoroacetamide Chemical compound FCC(=O)NC1=CC=C(Br)C=C1 ACCDBHBOYZJSDT-UHFFFAOYSA-N 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000001076 sarcopenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000152 swallowing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/101—Addition of antibiotics, vitamins, amino-acids, or minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
- A23L23/10—Soup concentrates, e.g. powders or cakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0626—Isoleucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0628—Leucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0654—Valine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1642—Zinc
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/702—Vitamin A
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cereal-Derived Products (AREA)
Abstract
Description
본 발명은 완두콩과 쌀혼합물 및 미강을 함유하는 고단백질 기능성 죽 프리믹스의 제조방법에 관한 것이다. 보다 상세하게는 통쌀, 쌀 그리츠 및 쌀 분말로 이루어진 쌀 혼합물 60∼99 w% 및 안정화된 미강 분말 1∼40 w%로 구성된 죽 프리믹스에 있어서, 단백질원으로 완두콩 분말 10∼50 w%을 포함하고, 분지아미노산 1~10%, 비타민 A 70∼80ug RAE/100g, 비타민 B2(리보플라빈) 0.14∼0.16mg/100g, 비타민 C 8∼12mg/100g을 포함하고, 칼슘 70∼90mg/100g, 아연 8∼12mg/100g, 마그네슘 50∼70mg/100g을 포함하는 단백질 고기능성 죽 프리믹스 및 그 제조방법에 관한 것이다.The present invention relates to a method for producing a high-protein functional porridge premix containing a mixture of peas and rice and rice bran. More specifically, a porridge premix consisting of 60-99 w% of a rice mixture consisting of whole rice, rice grits and rice powder and 1-40 w% of stabilized rice bran powder, containing 10-50 w% of pea powder as a protein source 1-10% of branched amino acids, vitamin A 70-80ug RAE/100g, vitamin B2 (riboflavin) 0.14-0.16mg/100g, vitamin C 8-12mg/100g, calcium 70-90mg/100g, zinc 8 It relates to a protein porridge premix containing ~12mg/100g and magnesium 50~70mg/100g and a manufacturing method thereof.
죽(粥, rice porridge)은 곡식이나 전분을 함유한 식재료를 분쇄하여 물과 함께 끓여 알갱이가 무르게 만든 것으로 소화가 잘 되는 특징이 있다. 따라서 환자 또는 유아들에게 제공하는 식사이기도 하지만, 정상인도 전복죽, 닭죽, 야채죽, 팥죽 등을 보양식이나 기호식으로 먹기도 한다. 의료기술이 발달하고 국민건강보험의 혜택이 확산되면서 평균수명이 늘어 노인인구가 급증하면서 초고령화사회로 접어들고 있다. 대부분의 노인환자는 노인병원이나 노인요양원 및 주야간보호시설에 의지하여 국민건강보험공단의 장기요양지원금 혜택을 지원받고 있다. 이러한 노인전문요양시설은 전국적으로 5,000여개가 넘고 있으며 급속도로 증가하고 있는 추세이다. 입원한 노인환자들 중 하루 3끼니를 죽으로 해결하는 노인환자는 대략 30%에 육박하고 있는 실정이다. 종래에 죽을 만드는 방법은 쌀을 물에 침지시킨 다음 끓이는데 시간이 걸리고, 조리인력이 필요하여 노인요양시설 입주자에게 대량의 죽을 제공하는데 어려움이 있고, 노인환자의 식사대용으로서 영양성분이 부족하고, 목넘김성이 불편하다는 문제점이 있다. 또 다른 방법은 쌀을 미쇄하게 분쇄한 다음 끓여서 죽을 제조하는 방법도 있으나 이 경우에는 미음처럼 죽이 만들어져 취식자가 음식을 씹는 활동을 거의 하지 못하게 됨으로써 저작감이 저하되어 식사 대용 음식으로서 그 활용도가 떨어진다는 문제점이 있다. 따라서 죽을 짧은 시간 내에 만들 수 있고 부드러운 식감과 저작감을 동시에 느끼면서 영양적인 만족과 면역력이 있는 노인환자의 식사 대용식이나 유아의 이유식으로서 기능성 죽이 절실히 필요한 실정이다. Porridge (粥, rice porridge) is made by pulverizing grains or starch-containing ingredients and boiling them with water to soften the grains. It is characterized by easy digestion. Therefore, it is a meal provided to patients or infants, but normal people also eat abalone porridge, chicken porridge, vegetable porridge, red bean porridge, etc. as a health food or a favorite food. With the development of medical technology and the spread of the benefits of national health insurance, the average life expectancy has increased, and the elderly population is rapidly increasing, entering a super-aged society. Most elderly patients rely on hospitals for the elderly, nursing homes for the elderly, and day and night care facilities to receive long-term care subsidies from the National Health Insurance Corporation. There are more than 5,000 such specialized nursing facilities for the elderly nationwide, and they are rapidly increasing. Among the elderly patients who are hospitalized, the elderly patients who solve three meals a day with porridge are close to 30%. In the conventional method of making porridge, it takes time to immerse rice in water and then boil it, and it is difficult to provide a large amount of porridge to residents of an elderly care facility because cooking personnel are required, and nutrients are insufficient as a meal replacement for elderly patients, There is a problem that the throat is inconvenient. Another method is to grind rice finely and then boil it to make porridge. has a problem. Therefore, porridge can be made in a short time, and functional porridge is urgently needed as a meal replacement for elderly patients with nutritional satisfaction and immunity while feeling soft texture and chewing at the same time, or as weaning food for infants.
동식물은 두종류의 면역 시스템 즉, 선천성 면역(innate immunity)은 비특이적 면역(자연면역, 내재면역) 방법으로 숙주가 감염되지 않도록 방어하는 세포나 면역 메커니즘이다. 특정의 병원체, 항원을 기억하지 않고 즉각적으로 반응하는 면역시스템을 가지고 있다. 대식세포와 같은 식세포나 체내의 항생 물질 등이 체내 면역에서 중요한 역할을 수행하는데, 선천성 면역세포에서 분비되는 대표적인 사이토카인은 인터류킨6(IL-6), 인터류킨12(IL-12), 종양괴사인자-알파(tumor necrosis factoralpha; TNF-α)이다. 한편 후천성 면역(acquired immunity)은 특이적 면역(적응 면역, 획득 면역)은 항원에 노출된 후에 유도되는데, 미래에 같은 항원에 노출되면 기억된 면역 작용이 유도된다. 고등 생명체에서 병원체에 노출된 개체의 감염 초기에 후천 면역이 작동하지 않는 기간에는 선천 면역이 우선 작동하고, 뒤이어 보다 효율적인 후천 면역이 작동한다. 후천 면역 과정은 B-세포나 T-세포 등이 주도적인 역할을 수행하는데, 후천성 면역세포에서 분비되는 대표적인 사이토카인은 인터류킨2(IL-2)와 인터페론-감마(interferon-gamma, IFN-γ)이다.Animals and plants have two types of immune systems, that is, innate immunity is a cell or immune mechanism that protects a host from infection by non-specific immunity (natural immunity, innate immunity). It has an immune system that responds immediately without remembering specific pathogens and antigens. Phagocytes such as macrophages and antibiotics in the body play an important role in in vivo immunity. Representative cytokines secreted from innate immune cells are interleukin 6 (IL-6), interleukin 12 (IL-12), and tumor necrosis factor -alpha (tumor necrosis factoralpha; TNF-α). On the other hand, acquired immunity is induced after specific immunity (adaptive immunity, acquired immunity) is exposed to an antigen, and when exposed to the same antigen in the future, a memorized immune action is induced. In higher organisms, during a period in which acquired immunity does not operate at the beginning of infection of an individual exposed to a pathogen, innate immunity operates first, followed by more efficient acquired immunity. In the acquired immune process, B-cells and T-cells play a leading role. Representative cytokines secreted from acquired immune cells are interleukin 2 (IL-2) and interferon-gamma (IFN-γ). am.
완두콩(peas)은 쌍떡잎식물로서 장미목 콩과의 한·두해살이풀이다. 완두콩은 팥이나 강낭콩 처럼 밥밑용, 떡.과자의 고물, 성숙하기 전의 푸른 씨알은 통조림으로, 어린 꼬투리는 채소로, 잎·줄기는 가축의 사료(飼料)로 이용되고, 단백질, 복합탄수화물, 섬유질, 무기질, 비타민 및 항산화 물질을 포함하여 우수한 영양 급원으로 이용되고 있다. 완두의 일반성분은 수분 8.1g, 단백질 20.7 g, 탄수화물 65.1g. 지질 1.3g, 회분 2.8 g 이다. 완두콩(100g에 식이섬유 6g 함유)의 식이섬유는 노폐물의 배출과 장건강에 도움을 주며, 오메가3 지방산이 함유되어 있어 뇌세포 활동을 촉진하며, 지방산으로 리노렌산과 올레인산이 함유되어 콜레스테롤 수치를 내려주고 칼륨이나 나트륨 배출을 도와 혈관 건강에 도움을 주며, 이소플라본 성분이 항산화제 역할을 하여 유해산소를 없애주고 사포닌과 비타민K가 함유되어 암세포의 성장을 억제하는데 도움을 준다. 완두콩은 조단백질 14∼31%, 알부민 15∼25%, 글로부린 49∼70%, 글루테린 11%, 프로라민 5%, 라이신 8.9%, 글루타민 11%, 시스틴, 아르기닌 등이 들어 있고 미네랄, 비타민B1이 함유되어 근육 손실을 막아주고 단백질 합성을 돕는 아미노산이 풍부해 근육을 증가시켜 주는데 도움을 준다. 완두콩은 장건강, 두뇌건강, 혈관건강, 근육증가, 암예방등에 좋다고 알려져 있다., Peas are a dicotyledonous plant and an annual or biennial plant belonging to the leguminous rose family. Green peas, like adzuki bean or kidney bean, are used under rice, rice cakes and snacks, blue seeds before maturity are canned, young pods are used as vegetables, leaves and stems are used as feed for livestock, and are rich in protein, complex carbohydrates, and fiber. It is used as an excellent source of nutrients, including minerals, vitamins and antioxidants. The general components of peas are 8.1 g of water, 20.7 g of protein, and 65.1 g of carbohydrates. It is 1.3 g of lipid and 2.8 g of ash. Dietary fiber in peas (100g contains 6g of dietary fiber) helps to discharge waste and promote intestinal health, contains omega-3 fatty acids to promote brain cell activity, and contains linoleic acid and oleic acid to lower cholesterol levels. The isoflavone component acts as an antioxidant to eliminate free radicals and contains saponin and vitamin K to help inhibit the growth of cancer cells. Peas contain 14-31% of crude protein, 15-25% of albumin, 49-70% of globulin, 11% of gluterin, 5% of prolamin, 8.9% of lysine, 11% of glutamine, cystine and arginine, and are rich in minerals and vitamin B1. It contains amino acids that prevent muscle loss and help protein synthesis, which helps increase muscle mass. Green peas are known to be good for intestinal health, brain health, blood vessel health, muscle growth, and cancer prevention.
콩(soy bean)은 단백질 35~47%, 탄수화물 30%, 지방 15~20% 가량으로 구성되어 있으며 식이섬유, 인, 철, 칼슘, 비타민B1이 풍부한 영양 식품이다. 콩은 아미노산의 종류도 다양하여 글리신과 아르기닌 등 생명 유지에 중요한 필수아미노산 함량이 높고 질 좋은 단백질을 공급한다. 위와 장에서 포도당의 흡수 속도를 낮춰 당뇨병을 억제하며 식물성 에스트로겐인 이소플라본이 풍부하게 들어 있어 골다공증 예방에도 좋다. 비타민E가 풍부해 혈액순환을 원활하게 함으로써 노화를방지해 주며, 장내 장 운동을 촉진시키는 비피더스균을 활성화해 변비 치료에도 효과가 있다. 제니스틴, 사포닌, 피트산, 파이토스테롤 등 콩에 들어 있는 기능 성분은 유방암, 직장암, 결장암, 폐암, 위암, 전립선암 감소에 도움을 준다고 한다. 콩의 레시틴은 뇌의 집중력을 향상시키며 치매와 건망증을 개선하고 뇌의 노화를 방지하는 효과가 있다. 대두의 이소플라본은 체내 콜레스테롤을 줄이고 여성 호르몬인 에스트로겐이 과다하게 분비되는 것을 억제해 주는 작용을 해 유방암과 난소암 등을 예방하고 갱년기 증상을 완화한다. 성인병과 탈모 예방은 물론 다이어트에도 효과적이며 검은색 껍질에 포함된 안토시아닌 색소는 유해한 활성 산소를 없애 주는 강력한항산화 성분이 있어 항암과 노화 예방에 도움을 준다. 특히 검은콩은 세계 10대 푸드로 선정된 바 있어 파워푸드로도 불린다. Soybean is composed of 35-47% protein, 30% carbohydrate, and 15-20% fat, and is a nutritious food rich in dietary fiber, phosphorus, iron, calcium, and vitamin B1. Soybeans also have a variety of amino acids, so they provide high-quality protein with high content of essential amino acids important for life, such as glycine and arginine. It suppresses diabetes by lowering the absorption rate of glucose in the stomach and intestines, and is rich in isoflavones, which are plant estrogens, so it is good for preventing osteoporosis. Rich in vitamin E, it prevents aging by facilitating blood circulation, and it is effective in treating constipation by activating bifidobacteria that promote intestinal movement. Functional ingredients in soybeans, such as genistine, saponin, phytic acid, and phytosterol, are said to help reduce breast, rectal, colon, lung, stomach, and prostate cancers. Soybean lecithin improves brain concentration, improves dementia and forgetfulness, and has the effect of preventing brain aging. Soybean isoflavones reduce cholesterol in the body and suppress excessive secretion of estrogen, a female hormone, preventing breast and ovarian cancer and alleviating menopausal symptoms. It is effective for dieting as well as preventing adult diseases and hair loss. The anthocyanin pigment contained in the black peel has a strong antioxidant component that eliminates harmful active oxygen, helping to prevent cancer and aging. In particular, black soybeans have been selected as one of the world's top 10 foods, and are also called power foods.
분지아미노산(Branched Chain Amino Acid; BCAA)은 발린(valine), 루이신(Leucine), 이소루이신(Isoleucine) 등 곁사슬에 분지알칼리가 있는 아미노산으로 소수성 아미노산이기도 하다. 효소 등인 활성중심의 주머니에서 결합부위의 형성에 기여하고 있다. 루이신은 α나선구조의 형성을 촉진하고, 발린, 이소류신은 β구조에 존재하는 경우가 많다. 이들은 사람에 있어서는 영양면에서는 필수아미노산에 속한다. BCAA의 3종은 간을 거치지 않고 근육으로 곧바로 가서 대사가 이루어지고 근육에서 필요한 에너지를 주게 되어 근육의 생성을 돕고 근육세포의 활성을 도와준다. 특히 노인환자나 수술환자는 섭취한 단백질이 아미노산으로 분해되는 비율이 낮고, 다시 근육단백질로 재건되는 비율이 낮다. 특히 분지아미노산 중의 루이신은 근육감소증 치료의 보조제로 쓰인다. Branched Chain Amino Acids (BCAAs) are amino acids with branched alkalis in their side chains, such as valine, leucine, and isoleucine, and are also hydrophobic amino acids. It contributes to the formation of binding sites in the pockets of active centers, such as enzymes. Leucine promotes the formation of the α-helical structure, and valine and isoleucine are often present in the β structure. These are essential amino acids in terms of nutrition for humans. The three types of BCAA go directly to the muscle without going through the liver, where they are metabolized and provide the necessary energy in the muscle to help create muscle and help activate muscle cells. In particular, elderly patients or patients with surgery have a low rate of ingested protein being broken down into amino acids and a low rate of being rebuilt into muscle protein. In particular, leucine among branched amino acids is used as an adjuvant in the treatment of sarcopenia.
완두콩에 관련된 종래기술로는 한국특허등록번호 10-2028652(완두콩 분말, 발효미강, 쌀의눈, 당귀 추출분말, 인삼 추출분말, 꿀분말 및 코코아분말을 포함하는 분말 형태의 종합영양보조식품)는 완두콩 분말, 발효미강, 쌀의눈, 당귀 추출분말, 인삼 추출분말, 꿀분말 및 코코아분말을 포함하는 분말 형태의 종합영양보조식품에 관한 것이다. 한국특허공개번호 10-2021-0008845(가수분해된 완두콩 단백질 기반의 영양 조성물)는 완두콩 단백질 가수분해물을 포함하는 적어도 하나의 단백질 공급원은 전체 조성물의 2.25 wt%~6.5 wt%을 구성하고; 하나 이상의 식물화학 추출물; 하나 이상의 지방산; 하나 이상의 유기농 성분; 및 하나 이상의 프리바이오틱 섬유를 포함하는 영양 조성물이다. 한국특허공개번호 10-2021-0020080(온전한 완두콩 단백질 기반의 영양 조성물)은 장내, 경구로 투여용 온전한 완두콩 단백질 기반의 영양 조성물로서, 유기농 그리고 식물-기반의 성분들로 만들어진다. 상기 영양 조성물은 완두콩 단백질, 식물화학 추출물, 지방산, 상위 8개의 알레르겐이 없는 유기농성분들, 그리고 프리바이오틱 섬유를 포함한다. 상기 영양 조성물은 장내로 그리고 경구로 투여를 위해 액체 형태로 제공된다. 그러나 이들 종래기술은 본 발명과 기술적구성이 다른 것이다.As for the prior art related to peas, Korea Patent Registration No. 10-2028652 (comprehensive nutritional supplement in powder form including pea powder, fermented rice bran, rice buds, angelica extract powder, ginseng extract powder, honey powder and cocoa powder) is It relates to a comprehensive nutritional supplement in powder form including pea powder, fermented rice bran, rice buds, angelica extract powder, ginseng extract powder, honey powder and cocoa powder. Korean Patent Publication No. 10-2021-0008845 (a nutritional composition based on hydrolyzed pea protein) discloses that at least one protein source comprising a pea protein hydrolyzate constitutes 2.25 wt% to 6.5 wt% of the total composition; one or more phytochemical extracts; one or more fatty acids; one or more organic ingredients; and one or more prebiotic fibers. Korean Patent Publication No. 10-2021-0020080 (nutritional composition based on whole pea protein) is a nutritional composition based on whole pea protein for enteral and oral administration, and is made of organic and plant-based ingredients. The nutritional composition includes pea protein, phytochemical extracts, fatty acids, top 8 allergen-free organic ingredients, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and oral administration. However, these prior arts are different in technical configuration from the present invention.
본 발명자는 쌀 혼합물 및 안정화된 미강을 함유하는 기능성 죽 프리믹스 및 이의 제조방법에 관한 특허등록번호 10-1441565를 개시한 바 있다. 통쌀, 쌀 그리츠(grits) 및 쌀 분말로 이루어진 쌀 혼합물 60∼99 w% 및 안정화된 미강 분말 1∼40 w%를 포함하는 죽 프리믹스에 관한 것이다. 그러나 쌀 혼합물에 함유된 단백질은 7∼8 g/100g 정도로서 한끼 죽으로는 단백질 함량이 낮아서 식사대용으로는 불완전한 점이 있었다. 따라서 본 발명은 상기 죽 프리믹스에 부족한 단백질을 보강하기 위하여 연구를 거듭한 끝에 조단백질의 함량이 높은 콩류 중에서 물성과 맛이 좋은 완두콩을 첨가하고, 그밖에 분지아미노산, 비타민과 미네랄을 첨가하여 기능성 죽 프리믹스를 제조하는 방법을 완성하게 되었다. The present inventors have disclosed Patent Registration No. 10-1441565 relating to a functional porridge premix containing a rice mixture and stabilized rice bran and a method for preparing the same. It relates to a porridge premix comprising 60 to 99 w% of a rice mixture consisting of whole rice, rice grits and rice powder, and 1 to 40 w% of stabilized rice bran powder. However, the protein contained in the rice mixture was about 7-8 g/100 g, and the protein content was low for a meal, so it was incomplete as a meal replacement. Therefore, the present invention, after repeated research to reinforce insufficient protein in the porridge premix, added peas with good physical properties and taste among legumes with high crude protein content, and added branched amino acids, vitamins and minerals to obtain a functional porridge premix. The manufacturing method was perfected.
본 발명자가 개시한 특허등록번호 10-1441565(쌀 혼합물 및 안정화된 미강을 함유하는 기능성 죽 프리믹스 및 이의 제조방법)는 (S1) 쌀을 분쇄하여 3가지 입도 크기를 갖는 통쌀, 쌀 그리츠 및 쌀 분말로 구분하여 준비하는 단계; (S2) 상기 통쌀, 쌀 그리츠 및 쌀 분말을 2.5∼3.5 : 4.5∼5.5 : 1.5∼2.5의 중량비로 혼합하는 단계; (S3) 상기 혼합된 쌀 혼합물 60∼99 중량% 및 안정화된 미강 분말 1∼40 w%를 혼합하여 죽 프리믹스를 수득하는 단계로 구성되어 있다. 본 발명자는 상기에서 개시한 특허등록번호 10-1441565의 '쌀 혼합물 및 안정화된 미강을 함유하는 기능성 죽 프리믹스'의 단점인 부족한 단백질을 보충하기 위하여 동물성단백질 중의 계란단백이나 유청단백 또는 식물성단백질 중의 콩(대두), 완두콩, 렌틸콩 중에서 완두콩을 선택하게 되었다. 완두콩은 앙금이나 고물로 널리 사용되어 소비자에게 익숙할 뿐만 아니라, 영양성과 물성 그리고 맛이 좋으면서 쌀 혼합물과 친화력이 좋은 소재이다. 특히 노인환자는 소화력이 떨어지고 음식물을 씹는 저작감이 부족하며 목넘김에 불편한 점을 고려하였다. 콩은 지방질 함량이 높은 장점이 있으나, 프리믹스의 소재로 사용하려면 콩의 지방을 제거해야 하고, 탈지대두는 조직이 단단하여 저작성과 목넘김성이 나쁘기 때문에 콩 보다는 부드럽고 맛이 좋은 완두콩을 프리믹스 소재로 선택하게 되었다. 완두콩을 브랜칭 및 급속냉각 시켜서 효소작용이 억제되어 영양성분의 손실 방지와 풍미를 유지시킬 수 있다. 또한 브랜칭 및 급속냉각한 완두콩을 분쇄한 다음 효소분해시켜 노인환자에게 흡수가 용이하도록 한다. 본 발명은 완두콩을 정제수로 세척 침지시킨 다음, 물기를 제거하여 고온에서 살균 및 브랜칭한 완두콩을 저온에서 급속냉각한 완두콩을 분쇄하는 단계와, 완두콩분말에 10배의 정제수를 가하여 균질화한 다음, 공지의 상업용 단백분해효소를 이용하여 가수분해시키는 단계와, 상기의 가수분해물을 열처리하여 효소반응을 정지시킨 다음 원심분리하여 완두콩 효소분해물을 얻는 단계와, 상기의 효소분해물을 건조한 다음, 사별하고 이물질을 제거하는 단계와, 완두콩 분말, 쌀 혼합물(통쌀, 쌀그리츠, 쌀분말), 미강 분말, 분지아미노산 및 미량의 비타민과 미네랄을 혼합하여 죽 프리믹스를 만드는 단계로 구성되는 단백질 고기능성 죽 프리믹스의 제조방법이다.Patent Registration No. 10-1441565 (Functional Porridge Premix Containing Rice Mixture and Stabilized Rice Bran and Manufacturing Method thereof) disclosed by the present inventors (S1) by pulverizing rice to have three grain sizes: whole rice, rice grits, and rice Preparing by dividing into powder; (S2) mixing the whole rice, rice grits, and rice powder in a weight ratio of 2.5 to 3.5: 4.5 to 5.5: 1.5 to 2.5; (S3) mixing 60-99% by weight of the mixed rice mixture and 1-40% by weight of stabilized rice bran powder to obtain a porridge premix. In order to supplement the lack of protein, which is a disadvantage of the 'functional porridge premix containing rice mixture and stabilized rice bran' of Patent Registration No. 10-1441565 disclosed above, the present inventors have found that egg protein or whey protein in animal protein or soybean in vegetable protein (soybeans), peas, and lentils, so I chose peas. Peas are not only familiar to consumers as they are widely used as sediment or sediment, but also have good nutritional properties, good taste, and good affinity with rice mixtures. In particular, elderly patients have poor digestion, lack of chewing sensation, and discomfort in swallowing food. Soybean has the advantage of high fat content, but to use it as a material for premix, the fat of soybean must be removed, and defatted soybean has a hard texture and has poor chewing and swallowing properties. I did. By branching and rapidly cooling peas, enzymatic action is inhibited, preventing loss of nutrients and maintaining flavor. In addition, the branched and rapidly cooled peas are pulverized and then enzymatically digested so that the elderly patients can easily absorb them. The present invention includes the steps of washing and immersing peas in purified water, removing water, sterilizing and branching peas at high temperature, grinding peas rapidly cooled at low temperature, adding 10 times purified water to pea powder to homogenize, and then known Hydrolysis using a commercial protease, heat treatment of the hydrolyzate to stop the enzymatic reaction, centrifugation to obtain a pea enzyme hydrolyzate, drying the enzyme hydrolyzate, and then separating and removing foreign substances A method for producing a protein high-functional porridge premix comprising the step of removing and mixing pea powder, rice mixture (whole rice, rice grits, rice powder), rice bran powder, branched amino acids, and trace amounts of vitamins and minerals to make a porridge premix. am.
상기의 식물성 원료 중에서 단백질 함유량이 높은 콩(대두), 렌틸콩, 잠두콩 중에서 선택된 어느 하나 또는 둘이상을 탈지, 분쇄 등의 전처리를 거친후 완두콩의 일부를 대체하여 완두콩과 함께 병용할 수 있다. 또한 분리대두단백이나 식물성단백질을 완두콩과 병용할 수 있다.Among the above vegetable raw materials, any one or two or more selected from soybeans (soybeans), lentils, and broad beans having high protein content may be used together with peas by replacing some of the peas after undergoing pretreatment such as degreasing and grinding. In addition, isolated soybean protein or vegetable protein can be used in combination with peas.
본 발명의 죽 프리믹스는 쌀 혼합물, 미강, 완두콩 단백질과 분지아미노산 및 비타민과 미네랄이 보강된 고기능성 단백질 죽을 제공할 수 있다. 특히 완두콩을 살균 및 브랜칭한 다음 급냉시켜 효소작용을 억제시켜 영양성분의 손실 방지와 풍미 유지에 도움을 줄 수 있다. 또한 단백분해효소로 가수분해시켜 단백질 함량을 높여 면역력과 체중이 유지되면서 노인환자에게 부드러운 목넘김성과 저작감으로 흡수가 용이하여 노인환자의 회복이 빠르다. 본 발명은 노인의 보양식, 성인의 식사대용식, 영유아의 영양식으로 이용될 수 있다.The porridge premix of the present invention can provide high-functional protein porridge supplemented with rice mixture, rice bran, pea protein, branched amino acids, and vitamins and minerals. In particular, peas can be sterilized and branched and then quenched to inhibit enzyme action, which can help prevent loss of nutrients and maintain flavor. In addition, it is hydrolyzed with a proteolytic enzyme to increase the protein content, while maintaining immunity and weight, and easy absorption by the elderly patients with soft throat and chewing sensation, so that the elderly patients recover quickly. The present invention can be used as a health food for the elderly, a meal replacement meal for adults, and a nutritional food for infants and young children.
도 1은 본 발명의 제조공정도이다.
도 2는 죽 프리믹스의 산화질소(NO) 생성량을 나타낸 것이다. N은 음성대조군, RP①(쌀혼합물+미강), RP②(쌀혼합물+미강+완두콩+분지아미노산+비타민+미네랄)을 나타낸 것이다.
도 3은 선천성 면역과 관련하여 RP①과 RP②의 IL-6와 IL-12, TNF-α의 발현량을 나타낸 것이다.
도 4는 후천성 면역과 관련하여 RP①과 RP②의 IL-2, IFN-γ의 발현량을 나타낸 것이다.
도 5 a는 고온살균 블랜칭 기술을 이용한 완두콩분말이고, 도 5b는 완두콩분말이 함유된 죽프리믹스이고, 도 5c는 완두콩분말이 함유된 죽프리믹스로 조리된 죽이다.
도 6a는 주사전자현미경(SEM) 1,000배(S-3400N, Hitachi/Japan)로 찍은 쌀분말 사진으로서 경질의 미립자들이 뭉치는 현상을 나타내고 있다. 6b는 완두콩분말 사진으로 연질의 원형 입자가 별개로 분리된 현상을 나타내고 있다. 1 is a manufacturing process diagram of the present invention.
2 shows the amount of nitrogen oxide (NO) produced in the porridge premix. N represents the negative control group, RP① (rice mixture + rice bran) and RP② (rice mixture + rice bran + peas + branched amino acids + vitamins + minerals).
Figure 3 shows the expression levels of IL-6, IL-12, and TNF-α in RP① and RP② in relation to innate immunity.
Figure 4 shows the expression levels of IL-2 and IFN-γ in RP① and RP② in relation to acquired immunity.
Figure 5a is pea powder using high-temperature sterilization blanching technology, Figure 5b is a porridge premix containing pea powder, Figure 5c is porridge cooked with a porridge premix containing pea powder.
6a is a photograph of rice powder taken with a scanning electron microscope (SEM) 1,000 times (S-3400N, Hitachi/Japan), showing a phenomenon in which hard fine particles are agglomerated. 6b is a photograph of pea powder, showing a phenomenon in which soft circular particles are separated.
본 발명의 완두콩의 브랜칭 기술을 도입한 기능성 단백질 죽 프리믹스 제조공정은 아래와 같다. 완두콩을 정제수로 세척하여 침지시킨 다음, 완두콩의 물기를 제거하는 단계와, 완두콩을 고온에서 살균하면서 블랜칭한 완두콩을 저온에서 급속으로 냉각한 완두콩을 분쇄하는 단계와, 완두콩분말에 정제수를 가하여 균질화한 다음, 상업용 단백분해효소를 첨가하여 진탕항온수조에서 가수분해시킨다. 상기의 가수분해물을 고온에서 열처리하여 효소를 실활시킨 다음 원심분리한 후, 완두콩 효소분해물을 얻는 단계와, 상기의 완두콩 효소분해물을 건조한 다음, 적당한 크기로 사별하고 이물질을 제거하는 단계와, 완두콩 분말, 쌀 혼합물(통쌀, 쌀그리츠, 쌀분말), 미강 분말, 분지아미노산 및 비타민과 미네랄을 혼합하여 죽 프리믹스를 만드는 단계로 구성된다. 상기에서 완두콩의 브랜칭은 콩이나 야채류의 효소작용을 억제하여 영양성분의 손실을 방지하고 풍미를 유지시킬 수 있다. 또한 상기에서 완두콩을 브랜칭한 다음 급속하게 냉각시킨후 파쇄하여 효소분해시키면 완두콩의 조직감을 향상시켜 물성과 맛이 좋아지며, 노인환자에게 흡수가 용이하다. 또한 효소처리 완두콩은 영양성이 우수한 반면 취반 후 경도가 높은 편으로 저작 및 소화성 개선된다.The functional protein porridge premix manufacturing process incorporating the pea branching technology of the present invention is as follows. Washing and immersing the peas in purified water, removing the water from the peas, sterilizing the peas at a high temperature and rapidly cooling the blanched peas at a low temperature, grinding the peas, and homogenizing by adding purified water to the pea powder Then, a commercial protease is added to hydrolyze in a shaking water bath. Heat treatment of the hydrolyzate at a high temperature to inactivate the enzyme, followed by centrifugation to obtain a pea enzyme hydrolyzate, drying the pea enzyme hydrolyzate, and then dividing the hydrolyzate into an appropriate size and removing foreign substances; Pea powder , rice mixture (whole rice, rice grits, rice powder), rice bran powder, branched amino acids, and a step of making porridge premix by mixing vitamins and minerals. In the above, the branching of peas can inhibit the enzymatic action of beans or vegetables to prevent loss of nutrients and maintain flavor. In addition, if the peas are branched, rapidly cooled, and then crushed and enzymatically decomposed, the texture and taste of the peas are improved, and the absorption is easy for the elderly. In addition, while enzyme-treated peas have excellent nutrition, chewing and digestibility are improved due to their high hardness after cooking.
1) 완두콩의 세척, 침지, 탈수1) Washing, soaking and dehydration of peas
시중에서 구입(가락시장)한 완두콩을 흐르는 물이나 정제수로 깨끗이 세척한다. 세척한 완두콩을 18∼25℃의 정제수에 3~4시간 동안 침지시켜 충분하게 불린후, 완두콩을 채반위에서 4~5시간 동안 물기를 제거한다. Clean the peas purchased from the market (garak market) with running water or purified water. After immersing the washed peas in purified water at 18-25 ° C. for 3-4 hours and sufficiently soaking them, the peas are drained on a sieve for 4-5 hours.
2) 완두콩의 브랜칭과 급속냉각 및 분쇄2) Branching, rapid cooling and crushing of peas
완두콩을 78∼82℃에서 20~30분 동안 브랜칭하면서 살균한 완두콩을 0~5℃에서 1~2시간 동안 급속냉각한다. 상기의 급속냉각한 완두콩을 90~100 Mesh로 분쇄한다. 상기에서 완두콩의 브랜칭은 콩이나 야채류의 효소작용을 억제하여 영양성분의 손실을 방지하고 풍미를 유지시킬 수 있다. 또한 브랜칭한 후 급속냉각한 완두콩은 부드러운 조직감을 부여해 줄 수 있다. The peas were sterilized while branching at 78-82 ° C for 20-30 minutes. Rapid cooling at 0-5℃ for 1-2 hours. Crush the rapidly cooled peas with 90 to 100 mesh. In the above, the branching of peas can inhibit the enzymatic action of beans or vegetables to prevent loss of nutrients and maintain flavor. In addition, peas rapidly cooled after branching can impart a soft texture.
3) 완두콩분말의 효소분해3) Enzymatic degradation of pea powder
물과 완두콩분말을 9∼10 : 1로 균질화시킨 다음, 상업용 단백분해효소 0.1∼1.0%(w/v)를 첨가하여 pH 4~5에서 40∼50℃로 10∼30분간 동안 진탕항온수조에서 가수분해시킨다. 산업용 단백분해효소는 Alcalase, Protamex, Neutrase, Esperase, Flavourzyme, Bromelan, Laminex Super 3G 또는 Maxazyme(NovoNordisk Biochem) 중에서 선택된 단백분해효소이다. 바람직하게는 Bromelain 1200GDU, Laminex Super 3G, Protamex 또는 Flavourzyme 중에서 선택된 어느하나 또는 둘이상을 0.2∼0.4%(w/v)를 첨가하여 효소분해시킨 다음, 95~100℃에서 30~50/sec 가열하여 효소를 불활성화 시킨다. 상기 가수분해물의 효소반응을 정지시킨 다음 11,000∼12,000×g에서 14∼16분간 원심분리한 후, 완두콩 효소분해물을 얻는다.Water and pea powder were homogenized at a ratio of 9-10: 1, and then 0.1-1.0% (w/v) of commercial protease was added and stirred at pH 4-5 at 40-50 ° C for 10-30 minutes in a shaking water bath. hydrolyze it The industrial proteolytic enzyme is a proteolytic enzyme selected from Alcalase, Protamex, Neutrase, Esperase, Flavorzyme, Bromelan, Laminex Super 3G or Maxazyme (NovoNordisk Biochem). Preferably, 0.2 to 0.4% (w/v) of any one or two or more selected from Bromelain 1200GDU, Laminex Super 3G, Protamex, or Flavorzyme is added to decompose the enzyme, and then heated at 95 to 100 ° C for 30 to 50 / sec. inactivate the enzyme. After stopping the enzymatic reaction of the hydrolyzate and centrifuging at 11,000 to 12,000 × g for 14 to 16 minutes, a pea enzyme hydrolyzate is obtained.
완두콩을 브랜칭하여 급냉시킨 후, 효소분해시 효소농도가 높을수록, 활성화시간이 길수록 경도는 낮아지는 현상을 나타내는 것을 알 수 있다.After branching and rapidly cooling the peas, it can be seen that the higher the enzyme concentration and the longer the activation time, the lower the hardness during enzyme degradation.
4) 효소분해물의 건조, 사별, 이물질 제거4) Drying, bereavement, removal of foreign substances of enzyme decomposition
완두콩 효소분해물을 50~60℃에서 7~8 시간 동안 수분함량 8~9%로 건조한 다음, 0.4∼0.6mm이하로 사별하고 철 또는 스텐레스 금속, 돌, 프라스틱 등의 이물질을 제거한다. Pea enzyme hydrolyzate is dried at 50 to 60 ° C for 7 to 8 hours with a water content of 8 to 9%, then separated to 0.4 to 0.6 mm or less, and foreign substances such as iron or stainless metal, stone, and plastic are removed.
5) 죽 프리믹스 혼합5) Porridge Premix Mixing
단백질 함량이 40∼60 w%인 완두콩 분말 10∼50 w%, 쌀 혼합물(통쌀, 쌀그리츠, 쌀분말) 60∼99 w% 및 미강 분말 1∼40 w%, 분지아미노산 1%~10%, 미량의 비타민과 미네랄을 혼합하여 죽 프리믹스를 만든다. 상기에서 분지아미노산은 로이신, 이소로이신, 발린이 1 : 0.5 : 0.5의 비율로 혼합되어 1%~10%를 포함할 수 있다. 상기에서 비타민은 비타민 A, B, C, D, E 및 K 등을 포함할 수 있으며, 바람직하게는 비타민 A, B, C 중에서 어느하나 이상을 포함할 수 있다. 상기 비타민은 죽프리믹스 100 중량부에 대하여 비타민 A 70∼80ug RAE/100g, 비타민 C 8∼12mg/100g, 비타민 B2(리보플라빈) 0.14∼0.16mg/100g을 포함할 수 있다. 상기에서 미네랄은 셀렌, 아연(또는 산화아연), 마그네슘, 구리 등을 포함할 수 있으나 이에 한정되지 않는다. 바람직하게는 칼슘, 아연, 마그네슘 중에서 어느하나 이상을 포함할 수 있다. 상기의 미네랄은 죽프리믹스 100 중량부에 대하여 칼슘 70∼90mg/100g, 아연 8∼12mg/100g, 마그네슘 50∼70mg/100g을 혼합하여 죽 프리믹스를 만든다. 미네랄은 면역 및 항염 기능에 도움을 준다. 이들 비타민과 미네랄은 우리나라 식품의약품안전처의 1일 영양요구량의 10%이상을 충족할 수 있다.10-50 w% pea powder with 40-60 w% protein content, 60-99 w% rice mixture (whole rice, rice grits, rice powder) and 1-40 w% rice bran powder, 1%-10% branched amino acids, A porridge premix is made by mixing trace amounts of vitamins and minerals. In the above, the branched amino acid may include 1% to 10% of leucine, isoleucine, and valine mixed at a ratio of 1: 0.5: 0.5. In the above, vitamins may include vitamins A, B, C, D, E, and K, and preferably include any one or more of vitamins A, B, and C. The vitamins may include 70-80ug RAE/100g of vitamin A, 8-12mg/100g of vitamin C, and 0.14-0.16mg/100g of vitamin B2 (riboflavin) based on 100 parts by weight of the porridge premix. In the above, the mineral may include selenium, zinc (or zinc oxide), magnesium, copper, and the like, but is not limited thereto. Preferably, one or more of calcium, zinc, and magnesium may be included. The above minerals make a porridge premix by mixing 70 to 90 mg/100 g of calcium, 8 to 12 mg/100 g of zinc, and 50 to 70 mg/100 g of magnesium based on 100 parts by weight of the porridge premix. Minerals help with immune and anti-inflammatory functions. These vitamins and minerals can meet more than 10% of the daily nutritional requirements of the Ministry of Food and Drug Safety in Korea.
쌀분말Control
rice powder
완두콩분말High-temperature sterilization and rapid cooling branching technology
Pea Powder
<실시예 1-4><Example 1-4>
완두콩 1kg을 상온의 정제수로 세척하여 완두콩과 정제수를 1 : 3의 비율로 3시간 동안 침지시킨 다음, 채반위에서 물기를 제거하고 탈수하였다. 완두콩을 80℃에서 30분간 블랜칭하여 효소를 실활시켰다. 또한 브랜칭한 완두콩을 0℃에서 1시간 동안 급속으로 냉각시켰다. 블랜칭 및 급속냉각된 완두콩을 55℃에서 8시간 동안 수분함량 8%로 건조한 다음, 90~100 Mesh로 분쇄하였다. 물과 완두콩분말을 10 : 1로 섞고 균질화시킨 다음, Bromelain 1200GDU, Laminex Super 3G, Protamex 또는 Flavourzyme 중에서 선택된 어느하나 또는 둘이상을 0.1∼1.0%(w/v)를 첨가하여 pH 4~5에서 40∼50℃로 10∼30분간 동안 진탕항온수조에서 가수분해시킨 다음, 95~100℃에서 30~50/sec 가열하여 효소를 불활성화 시킨다. 상기 가수분해물의 효소반응을 정지시킨 다음 11,000∼12,000×g에서 14∼16분간 원심분리한 후, 완두콩 효소분해물을 얻는다. 분쇄한 완두콩 분말 10∼50 w%를 쌀 혼합물 60∼99 w% 및 안정화된 미강 분말 1∼40 w%, 분지아미노산 1~10%, 비타민 3종의 비타민 A 75ug RAE/100g 이상, 비타민 C 10mg/100g 이상, 비타민 B2(리보플라빈) 0.15mg/100g 이상 및 미네랄 3종의 칼슘 80mg/100g 이상, 아연 10mg/100g 이상, 마그네슘 60mg/100g 이상(혼합 6종)을 혼합하여 죽 프리믹스를 제조하였다. 본 발명의 배합비에는 고령자의 소화, 저작, 영양기능을 보완하기 위하여 비타민3종 및 미네랄 3종을 1일 영양요구량의 10%이상을 충족할 수 있는 량을 포함하고 있다. 더욱이 본 발명의 "쌀혼합물 및 미강과 완두단백질 BCAA 아미노산이 혼합된 고단백질 기능성 죽 프리믹스(쇠고기야채죽)"를 한국기능식품연구원에 단백질과 분지아미노산 성분을 분석의뢰(2021.11.15.)하였던 바, 조단백질 18.08%, 루이신 3028mg/100g, 이소루이신 1494.93 mg/100g, 발린 1665.30 mg/100g 이 함유되었다는 결과를 얻었다. 이러한 단백질과 아미노산은 1일 영양소 요구량에 약 30%를 충족하는 매우 양호한 영양성분이라는 것을 알 수 있다. 본 발명자가 쇠고기야채죽프리믹스를 수원여자대학교에 영양성분 분석의뢰(2017.6.13)하였던바, 단백질 7.08mg/100g 이라는 결과를 얻은바 있다. 이와 비교해 볼 때 완두콩과 분지아미노산을 사용한 본 발명은 단백질 함량이 무려 3.9배이상 높아져 우수한 영양소임을 알 수 있다.1 kg of peas were washed with purified water at room temperature, immersed in peas and purified water at a ratio of 1: 3 for 3 hours, then drained and dehydrated on a sieve. Peas were blanched at 80° C. for 30 min to inactivate the enzyme. Branched peas were also rapidly cooled at 0 °C for 1 hour. Blanched and rapidly cooled peas were dried at 55 ° C. for 8 hours with a moisture content of 8%, and then pulverized with 90-100 mesh. After mixing water and pea powder at a ratio of 10:1 and homogenizing, 0.1∼1.0% (w/v) of any one or two or more selected from Bromelain 1200GDU, Laminex Super 3G, Protamex or Flavourzyme is added to pH 4-5 to 40 After hydrolysis in a shaking constant temperature water bath at ~50°C for 10~30 minutes, the enzyme is inactivated by heating at 95~100°C for 30~50/sec. After stopping the enzymatic reaction of the hydrolyzate and centrifuging at 11,000 to 12,000 × g for 14 to 16 minutes, a pea enzyme hydrolyzate is obtained. 10-50 w% of ground pea powder, 60-99 w% of rice mixture and 1-40 w% of stabilized rice bran powder, 1-10% of branched amino acids, 3 kinds of vitamin A 75ug RAE/100g or more, vitamin C 10mg / 100g or more, vitamin B2 (riboflavin) 0.15mg/100g or more, and three minerals of calcium 80mg/100g or more, zinc 10mg/100g or more, and magnesium 60mg/100g or more (6 types of mixture) were mixed to prepare a porridge premix. The blending ratio of the present invention contains 3 types of vitamins and 3 types of minerals in an amount that can satisfy 10% or more of the daily nutritional requirements in order to supplement digestion, chewing and nutritional functions of the elderly. Furthermore, the Korea Functional Food Research Institute was requested to analyze the protein and branched amino acid components of the "high-protein functional porridge premix (beef vegetable porridge) mixed with rice mixture and rice bran and pea protein BCAA amino acids" of the present invention (November 15, 2021). , Crude protein 18.08%, leucine 3028mg/100g, isoleucine 1494.93 mg/100g, valine 1665.30 mg/100g were contained. It can be seen that these proteins and amino acids are very good nutritional components that meet about 30% of the daily nutrient requirement. The present inventors requested nutritional analysis of beef vegetable porridge premix to Suwon Women's University (2017.6.13), and obtained a result of protein 7.08mg / 100g. Compared to this, the protein content of the present invention using peas and branched amino acids is more than 3.9 times higher, indicating that it is an excellent nutrient.
본 발명의 죽프리믹스는 활동성이 미약한 환자에게 제공되는 음식으로서 식이급여를 통하여 건강한 상태를 유지시키려면 면역체계의 손상이 없어야 하고, 체중의 변화가 없어야 한다. 따라서 면역력 시험 (in vitro)와 체중변화 (in vivo) 실험을 실시하였다.The porridge premix of the present invention is a food provided to patients with weak activity, and in order to maintain a healthy state through dietary benefit, there should be no damage to the immune system and no change in body weight. Therefore, an immunity test (in vitro) and a weight change (in vivo) experiment were conducted.
<실험예 1>; 면역력 시험 (in vitro)<Experimental Example 1>; Immunity test (in vitro)
쌀혼합물과 미강의 죽프리믹스①와 쌀혼합물에 미강과 완두콩 분지아미노산 및 비타민과 미네랄이 혼합된 고기능성 죽 프리믹스②를 대상으로 면역체계와 체중변화, 백혈구 및 DNA 손상여부를 실험하였다. Rice mixture and rice bran porridge premix ① and rice mixture mixed with rice bran and pea branched amino acids, vitamins and minerals, and highly
본 발명의 죽프리믹스①와 고기능성 죽 프리믹스②의 선천성 면역 증진 효과를 분석하기 위하여, 이들 추출물의 투여에 따른 산화질소(Nitric oxide) 생성량과 선천성 면역과 관련한 사이토카인인 interleukin의 IL-6와 IL-12, tumor necrosis factor-alpha의 TNF-α의 발현량을 측정하였다. In order to analyze the innate immunity enhancement effect of the porridge premix ① and the highly
1) Nitric oxide 생성량 측정1) Measurement of nitric oxide production
Mouse RAW 264.7 세포를 1Х105 cells/well의 농도로 48-wellplate에 넣은 후 LPS를 positive control로 하고 각각의 시료를 100 ㎍/mL 처리하였다. 24시간 배양한 후 세포배양 상층액을 얻었으며, Griess reagent를 활용하여 NO 생성량을 측정하였다. RP①(쌀혼합물+미강), RP②(쌀혼합물+미강+완두콩+비타민+미네랄)을 투여한 마우스 세포에서 Nitric oxide 생산량 측정 결과는 도 2에 나타낸 것과 같이 RP① 보다도 RP②에서 NO 생성량이 60% 이상 높은 것으로 나타났다. Mouse RAW 264.7 cells were placed in a 48-well plate at a concentration of 1Х10 5 cells/well, and each sample was treated with 100 μg/mL of LPS as a positive control. After culturing for 24 hours, the cell culture supernatant was obtained, and NO production was measured using Griess reagent. Nitric oxide production measurement results in mouse cells administered with RP① (rice mixture + rice bran) and RP② (rice mixture + rice bran + peas + vitamins + minerals) showed that NO production was 60% or more higher in RP② than in RP①, as shown in FIG. appeared to be
2) 선천성 면역과 관련 싸이토카인의 측정 2) Measurement of cytokines related to innate immunity
IL-6의 발현량 측정은 Mouse RAW 264.7 세포를 1Х105 cells /well의 농도로 48-well-plate에 넣은후 LPS를 positive control로 하고 시료를 100 ㎍/mL 처리하였다. 48시간 배양한 후 세포 배양 상층액을 얻었으며, ELISA kit를 이용하여 IL-6 생산량을 측정하였다. To measure the expression level of IL-6, Mouse RAW 264.7 cells were placed in a 48-well-plate at a concentration of 1Х10 5 cells /well, and the sample was treated with 100 μg/mL of LPS as a positive control. After culturing for 48 hours, the cell culture supernatant was obtained, and IL-6 production was measured using an ELISA kit.
IL-12의 발현량은 Mouse RAW 264.7 세포를 1 Х 105[0072] cells/well의 농도로 48-well cultureplates에 넣은 후 LPS를 positive control로 하고 시료를 100 ㎍/mL 처리하였다. 48시간 배양한 후 세포 배양상층액을 얻었으며, ELISA kit를 이용하여 IL-12 생산량을 측정하였다. For the expression level of IL-12, Mouse RAW 264.7 cells were placed in 48-well culture plates at a concentration of 1 Х 10 5 cells/well, and samples were treated with 100 μg/mL of LPS as a positive control. After culturing for 48 hours, the cell culture supernatant was obtained, and IL-12 production was measured using an ELISA kit.
TNF-α의 발현량 측정은 Mouse RAW 264.7세포를 1Х105 cells /well의 농도로 48-well-plate에 넣은 후 LPS를 positive control로 하고 시료를 100 ㎍/mL 처리하였다. 48시간 배양한 후 세포 배양 상층액을 얻었으며, ELISA kit를 이용하여 TNF-α 생산량을 측정하였다.To measure the expression level of TNF-α, Mouse RAW 264.7 cells were placed in a 48-well-plate at a concentration of 1Х10 5 cells /well, and then LPS was used as a positive control and the sample was treated at 100 μg/mL. After culturing for 48 hours, cell culture supernatants were obtained, and TNF-α production was measured using an ELISA kit.
RP①(쌀혼합물+미강), RP②(쌀혼합물+미강+완두콩+비타민+미네랄)을 투여한 마우스 세포에서 선천성 면역 사이토카인 IL-6, IL-12, TNF-α 생산량 측정 결과를 도 3에 나타냈다. 본 발명의 죽 프리믹스는 IL-6와 IL-12 사이토카인의 발현만이 증가하였고, TNF-α의 발현은 소량 증가한 것을 확인하였다.In the mouse cells administered with RP① (rice mixture + rice bran) and RP② (rice mixture + rice bran + peas + vitamins + minerals), the results of measuring the production of innate immune cytokines IL-6, IL-12, and TNF-α are shown in FIG. 3 . It was confirmed that the porridge premix of the present invention increased only the expression of IL-6 and IL-12 cytokines, and a small increase in the expression of TNF-α.
3) 후천성 면역 관련 싸이토카인 측정3) Measurement of acquired immunity-related cytokines
본 발명의 죽 프리믹스 RP①(쌀혼합물+미강)와 단백질 고기능성 죽 프리믹스RP②(쌀혼합물+미강+완두콩+비타민+미네랄)의 후천성 면역 증진 효과를 분석하기 위하여, 이들 추출물의 투여에 따른 사이토카인인 IL-2, interferon-gamma의 IFN-γ의 발현량을 측정하였다. In order to analyze the acquired immunity enhancement effect of the porridge premix RP① (rice mixture + rice bran) and protein high-functional porridge premix RP② (rice mixture + rice bran + peas + vitamins + minerals) of the present invention, cytokines according to the administration of these extracts The expression levels of IL-2 and interferon-gamma IFN-γ were measured.
IL-2의 발현량 측정은 Mouse 비장세포를 2Х106 cells/well의 농도로 48-well-plate에 넣은 후ConA를 positive control로 하고 시료를 100 ㎍/mL 처리하였다. 48시간 배양한 후 세포 배양 상층액을 얻었으며, ELISA kit를 이용하여 IL-2 생산량을 측정하였다. To measure the expression level of IL-2, mouse splenocytes were placed in a 48-well-plate at a concentration of 2Х10 6 cells/well, and ConA was used as a positive control and the sample was treated at 100 μg/mL. After culturing for 48 hours, the cell culture supernatant was obtained, and IL-2 production was measured using an ELISA kit.
IFN-γ의 발현량 측정은 Mouse 비장세포를 2Х106 cells /well의 농도로 48-well-plate에 넣은 후ConA를 positive control로 하고 시료를 100 ㎍/mL 처리하였다. 48시간 배양한 후 세포 배양 상층액을 얻었으며, ELISA kit를 이용하여 IFN-γ 생산량을 측정하였다. RP①(쌀혼합물+미강), RP②(쌀혼합물+미강+완두콩+비타민+미네랄)을 투여한 마우스 세포에서 후천성 면역 사이토카인 생산량 측정 결과를 도 4에 나타냈다. 근경 복합 식물 추출물을 투여한 마우스 세포에서 후천성 면역 사이토카인 IL-2와 IFN-γ 발현량은 모두 증가하는 것으로 나타났다. 이상의 결과로부터 본 발명의 죽 프리믹스는 산화질소 생성량 및 선천성 면역과 후천성 면역의 모든 사이토카인의 발현량이 증가하는 것을 알 수 있으므로 노인환자식에 적합하다.To measure the expression level of IFN-γ, mouse splenocytes were placed in a 48-well-plate at a concentration of 2Х10 6 cells /well, and ConA was used as a positive control and the sample was treated at 100 μg/mL. After culturing for 48 hours, cell culture supernatants were obtained, and IFN-γ production was measured using an ELISA kit. Figure 4 shows the acquired immune cytokine production measurement results in mouse cells administered with RP① (rice mixture + rice bran) and RP② (rice mixture + rice bran + peas + vitamins + minerals). In mouse cells administered with the rhizome complex plant extract, the expression levels of both acquired immune cytokines IL-2 and IFN-γ were increased. From the above results, it can be seen that the porridge premix of the present invention increases the amount of nitric oxide produced and the expression level of all cytokines of innate immunity and acquired immunity, so it is suitable for elderly patients.
<실험예 2>; 체중변화 (in vivo)<Experimental Example 2>; Weight change (in vivo)
본 발명의 죽 프리믹스①와 단백질 고기능성 죽 프리믹스②를 이용하여 실험동물(쥐)을 이용하여 체중변화를 시험하였다.Weight change was tested using experimental animals (rats) using the porridge premix ① and protein high-
본 발명의 죽프리믹스RP①(쌀혼합물+미강)와 단백질 고기능성 죽 프리믹스RP②(쌀혼합물 + 미강 + 완두콩 + 분지아미노산 + 비타민 + 미네랄)를 일반사료(LabDiet, Laboratory Rodent Diet 5001)의 각각 20%를 대체한 사료와 대조군으로 일반사료를 제조하였다. 6주령, 체중 20g ~ 25g인 수컷 C57 BL/6 마우스 10마리를 대상으로 2주간 섭취시키면서 상기의 ①과 ② 및 대조구의 1주 후, 2주 후 체중 변화, 2주 후 마우스 모두 부검하여 혈액을 채취하여 혈구분석기를 이용하여 백혈구수를 측정하였고 비장 말초 면역세포의 DNA 손상 정도를 comet assay를 통해 분석하였다. 개체당 일일 평균 사료섭취량 4.0 g/day이므로 14일간 섭취량은 56.0 g였으며, 모든 실험구 ①과 ② 및 대조구의 유의적 차이가 있었다. The porridge premix RP of the present invention (rice mixture + rice bran) and the protein high-functional porridge premix RP ② (rice mixture + rice bran + peas + branched amino acids + vitamins + minerals) were each 20% of the general feed (LabDiet, Laboratory Rodent Diet 5001). A replacement feed and a normal feed were prepared as a control group. 10 male C57 BL/6 mice aged 6 weeks and weighing 20 g to 25 g were fed for 2 weeks, and after 1 week and 2 weeks of the above ① and ② and control, body weight change after 2 weeks, and blood were necropsied after 2 weeks. After collection, the white blood cell count was measured using a hemacytometer, and the degree of DNA damage in peripheral immune cells in the spleen was analyzed using a comet assay. Since the average daily feed intake per individual was 4.0 g/day, the intake for 14 days was 56.0 g, and there was a significant difference between all
1) 체중변화1) Weight change
대조구의 일반사료 섭취구에 비하여 20%대체한 사료를 급여한 ①과 ②는 1% ∼ 3% 유의미한 체중 증가를 나타냈다. 상기의 결과로부터 본 발명의 단백질 고기능성 죽 프리믹스②를 급여한 사료가 죽프리믹스①과 대조군(일반사료)를 급여한 군에 비하여 1% 내지 3%의 체중증가를 나타냈다. 따라서 본 발명은 실험용 쥐의 체중증가를 가져오는 우수한 단백질 고기능성 죽 프리믹스라는 것을 알 수 있었다. ① and ②, which fed 20% substituted feed compared to the control group's general feed intake, showed a significant weight gain of 1% to 3%. From the above results, the feed fed the protein high-
2) 백혈구수2) white blood cell count
2주의 실험 기간 후 부검하여 백혈구수를 측정한 결과 실험구와 대조구의 백혈구수는 정상수치(1.8-10.7 K/μL) 범위에 있었다. 따라서 본 발명의 실험구 ①과 ② 및 대조구의 백혈구 수는 유의적 차이가 없었다. As a result of measuring the white blood cell count by autopsy after the 2-week experimental period, the white blood cell counts of the experimental and control groups were in the normal range (1.8-10.7 K/μL). Therefore, there was no significant difference in the number of leukocytes in the
3) DNA 손상3) DNA damage
DNA 손상 정도를 확인하기 위하여 comet assay를 수행한 결과 실험구와 대조구는 생체 내 DNA 손상으로부터 변화가 없다는 것을 확인하였다.As a result of performing a comet assay to confirm the degree of DNA damage, it was confirmed that there was no change from DNA damage in vivo in the experimental and control groups.
이상과 같은 실험 결과로부터 본 발명의 죽 프리믹스는 세포주실험(in vitro)과 동물실험(in vivo)을 통하여 면역력을 제공하면서, 체중을 증가시킬 수 있는 우수한 죽 프리믹스를 제공할 수 있다는 것을 알 수 있다.From the above experimental results, it can be seen that the porridge premix of the present invention can provide an excellent porridge premix that can increase body weight while providing immunity through cell line experiments (in vitro) and animal experiments (in vivo). .
본 발명은 쌀 혼합물, 미강, 완두콩 단백질, 분지아미노산 및 비타민과 미네랄이 보강된 고기능성 단백질 죽을 제공할 수 있다. 특히 완두콩을 브랜칭하여 급냉시키고 분쇄한 후, 단백분해효소로 가수분해시켜 단백질 함량을 높여 면역력과 체중이 유지되면서 노인환자에게 흡수가 용이하여 회복이 빠르다. 특히 보양식, 식사대용식, 영양식으로 이용 가능하므로 산업상 이용가능성이 있다.The present invention can provide a highly functional protein porridge supplemented with rice mixture, rice bran, pea protein, branched amino acids, and vitamins and minerals. In particular, peas are branched, quenched, pulverized, and then hydrolyzed with a proteolytic enzyme to increase protein content, maintaining immunity and weight, and being easily absorbed by elderly patients, so recovery is quick. In particular, since it can be used as health food, meal substitute, and nutritious food, it has industrial applicability.
Claims (10)
Protein high-functional porridge premix made by the method of any one of claims 5 to 9
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210174435A KR20230086836A (en) | 2021-12-08 | 2021-12-08 | A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same |
JP2022141906A JP7454281B2 (en) | 2021-12-08 | 2022-09-07 | Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same |
CN202211287644.4A CN116235923A (en) | 2021-12-08 | 2022-10-20 | High-functional protein porridge premix containing pea, rice mixture and rice bran and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210174435A KR20230086836A (en) | 2021-12-08 | 2021-12-08 | A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230086836A true KR20230086836A (en) | 2023-06-16 |
Family
ID=86635414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210174435A KR20230086836A (en) | 2021-12-08 | 2021-12-08 | A high protein functional porridge premix containing the rice mixture and stabilized rice bran and pea and the method of manufacturing the same |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7454281B2 (en) |
KR (1) | KR20230086836A (en) |
CN (1) | CN116235923A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102028652B1 (en) | 2018-08-03 | 2019-10-04 | 주식회사 휴바이오센트릭 | Powder type multiple food supplement comprising pisum sativum powder, fermented rice bran, embryo bud of rice, angelica gigas extract powder, ginseng extract powder, honey powder and cocoa powder |
KR20210008845A (en) | 2018-05-15 | 2021-01-25 | 케이트 팜스 인코포레이티드 | Nutritional composition based on hydrolyzed pea protein |
KR20210020080A (en) | 2018-06-12 | 2021-02-23 | 케이트 팜스 인코포레이티드 | Whole pea protein-based nutritional composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140046440A (en) | 2011-06-23 | 2014-04-18 | 이노바푸드 에이비 | Improved food composition |
KR101441565B1 (en) | 2013-05-24 | 2014-09-22 | (주)푸른가족 | A functional porridge premix containing the rice mixture and stabilized rice bran and the method of manufacturing the same |
CN107072276A (en) | 2014-09-01 | 2017-08-18 | 马修·乔利·瓦达科姆里 | A kind of nutraceutical of optimization |
CN108065414A (en) | 2016-11-15 | 2018-05-25 | 内蒙古伊利实业集团股份有限公司 | A kind of edible composition and its application with strengthen immunity |
JP6841444B2 (en) | 2019-06-04 | 2021-03-10 | 株式会社東洋新薬 | Immunostimulant |
-
2021
- 2021-12-08 KR KR1020210174435A patent/KR20230086836A/en not_active Application Discontinuation
-
2022
- 2022-09-07 JP JP2022141906A patent/JP7454281B2/en active Active
- 2022-10-20 CN CN202211287644.4A patent/CN116235923A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210008845A (en) | 2018-05-15 | 2021-01-25 | 케이트 팜스 인코포레이티드 | Nutritional composition based on hydrolyzed pea protein |
KR20210020080A (en) | 2018-06-12 | 2021-02-23 | 케이트 팜스 인코포레이티드 | Whole pea protein-based nutritional composition |
KR102028652B1 (en) | 2018-08-03 | 2019-10-04 | 주식회사 휴바이오센트릭 | Powder type multiple food supplement comprising pisum sativum powder, fermented rice bran, embryo bud of rice, angelica gigas extract powder, ginseng extract powder, honey powder and cocoa powder |
Non-Patent Citations (1)
Title |
---|
TEXTURIZATION OF PULSE PROTEINS: PEAS, LENTILS, AND FABA BEANS by TAEHOON KIM (dissertation). 2018. Submitted to the Office of Graduate and professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY. p 17. |
Also Published As
Publication number | Publication date |
---|---|
JP7454281B2 (en) | 2024-03-22 |
JP2023085194A (en) | 2023-06-20 |
CN116235923A (en) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qin et al. | A review on plant-based proteins from soybean: Health benefits and soy product development | |
Bau et al. | Effects of soybean (Glycine max) germination on biologically active components, nutritional values of seeds, and biological characteristics in rats | |
KR100734721B1 (en) | Vasodilator pharmaceutical preparation and health food composition | |
KR100899455B1 (en) | The soft autogeneous nutrition powder foodstuffs composition which does the wars powder with the principal ingredient and the manufacturing method | |
US6900173B2 (en) | Perioperative multivitamin protein bar for use in preparing an individual for fast surgical recovery | |
KR20030005086A (en) | Diet composition containing freeze-dried uncooked food and dietary fiber | |
KR102060283B1 (en) | Method for producing of natural powdered food comprising Tenebrio molitor powder with increased palatability | |
CN107927512A (en) | A kind of oligopeptide weight losing meal-replacing solid beverage | |
CN1558724A (en) | Herbal nutraceutical formulation for females/expectant mothers and its process of preparation | |
Oh et al. | Effects of Tenebrio molitor larvae and its protein derivatives on the antioxidant and anti-inflammatory capacities of tofu | |
KR102223506B1 (en) | Functional porridge using herbal ingredients and method for manufacturing the same | |
JP7454281B2 (en) | Highly functional protein porridge premix containing peas, rice mixture, and rice bran and method for producing the same | |
STODOLAK et al. | Effect of flaxseed oil-cake addition on the nutritional value of grass pea tempeh | |
KR20110118911A (en) | Lactic acid bacteria fermented extract using cereals and herb medicine materials, and method of preparing thereof | |
KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
KR101857065B1 (en) | The mineral-rich fermentation enzyme sunsik and a method of manufacturing | |
CN113662137A (en) | Slender black bean meal replacement powder and preparation method thereof | |
CN110214893A (en) | Full nutritious food of linseed bean powder and preparation method thereof | |
KR102300137B1 (en) | Low-carbohydrate diet bar and manufacturing method thereof | |
KR102649359B1 (en) | High-protein functional drink comprising of enzymatic hydrolysated wet-grinding Tenebrio molitor larva | |
KR102353951B1 (en) | Rice ball cake comprising bean curd and nuts and manufacturing method thereof | |
KR101174723B1 (en) | A composition constituting of raw soybeans and fermented soybeans | |
Zhang et al. | Soybean protein and soybean peptides: Biological activity, processing technology, and application prospects | |
KR101582832B1 (en) | A manufacturing method and the usage of water solubility granuled fermented bean | |
KR100348461B1 (en) | The soybean paste, cantained a lactobacillus and mainly stuffed with soybean powder, and the manufacturing method of the above paste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |